Filtered By:
Cancer: Prostate Cancer
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 25217 results found since Jan 2013.
LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients
CONCLUSIONS: Subclassification of IR prostate cancer into FIR and UIR subcategories appears mandatory. For FIR patients, outcomes after BT monotherapy were acceptable. However, clinical failure after 125J-LDR-BT in UIR patients was notably increased, suggesting that BT monotherapy was less successful in this risk group. In contrast, the outcome in UIR patients after CRT was excellent.PMID:37714724 | DOI:10.1016/j.urolonc.2023.08.007
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Andreas Boehle Dorothea Zywietz Irina Robrahn-Nitschke Achim Lusch Inke R K önig Source Type: research
Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer
CONCLUSION: Relugolix suppressed testosterone and was generally well tolerated when given with concomitant CV agents.TRIAL REGISTRATION: Clinical Trial ID NCT03085095.PRIOR PRESENTATION: Data presented at 15th Annual Genitourinary Cancers Symposium; February 17-19, 2022, San Francisco, CA, USA [Abstract 101, Poster board E11]. The published abstract from this presentation can be found at https://ascopubs.org/doi/10.1200/JCO.2022.40.6_suppl.101 .PMID:37713020 | DOI:10.1007/s12325-023-02634-7
Source: Adv Data - September 15, 2023 Category: Epidemiology Authors: Neal D Shore Bryan A Mehlhaff Michael S Cookson Daniel R Saltzstein Ronald Tutrone Bruce Brown Sophia Lu Mark Fallick Sarah Hanson Fred Saad Source Type: research
A systematic planning method to spare the rectal wall in radiotherapy of prostate cancer
Acta Oncol. 2023 Sep 15:1-4. doi: 10.1080/0284186X.2023.2252587. Online ahead of print.NO ABSTRACTPMID:37712583 | DOI:10.1080/0284186X.2023.2252587
Source: Acta Oncologica - September 15, 2023 Category: Cancer & Oncology Authors: Kirsten Jakobsen Laura Patricia Kaplan Romain Marsguerra Marko Bebek Kenneth Francis Hoffland Eva Samsoee Hinsby Source Type: research
LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients
CONCLUSIONS: Subclassification of IR prostate cancer into FIR and UIR subcategories appears mandatory. For FIR patients, outcomes after BT monotherapy were acceptable. However, clinical failure after 125J-LDR-BT in UIR patients was notably increased, suggesting that BT monotherapy was less successful in this risk group. In contrast, the outcome in UIR patients after CRT was excellent.PMID:37714724 | DOI:10.1016/j.urolonc.2023.08.007
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Andreas Boehle Dorothea Zywietz Irina Robrahn-Nitschke Achim Lusch Inke R K önig Source Type: research
Ki67 and prostate specific antigen are prognostic in metastatic hormone na ïve prostate cancer
CONCLUSION: PSA and Ki67 immunoreactive scores are prognostic in the metastatic hormone-sensitive setting, with PSA being superior. The combination of Ki67 and PSA did not give additional prognostic value. The results suggest immunohistochemical scoring of PSA to have potential to improve identification of patients responding well to ADT alone.PMID:37713321 | DOI:10.1080/0284186X.2023.2254480
Source: Acta Oncologica - September 15, 2023 Category: Cancer & Oncology Authors: Vasiliki Spyratou Eva Freyhult Anders Bergh Camilla Thellenberg-Karlsson Pernilla Wikstr öm Karin Wel én Andreas Josefsson Source Type: research
A systematic planning method to spare the rectal wall in radiotherapy of prostate cancer
Acta Oncol. 2023 Sep 15:1-4. doi: 10.1080/0284186X.2023.2252587. Online ahead of print.NO ABSTRACTPMID:37712583 | DOI:10.1080/0284186X.2023.2252587
Source: Acta Oncologica - September 15, 2023 Category: Cancer & Oncology Authors: Kirsten Jakobsen Laura Patricia Kaplan Romain Marsguerra Marko Bebek Kenneth Francis Hoffland Eva Samsoee Hinsby Source Type: research
Ki67 and prostate specific antigen are prognostic in metastatic hormone na ïve prostate cancer
CONCLUSION: PSA and Ki67 immunoreactive scores are prognostic in the metastatic hormone-sensitive setting, with PSA being superior. The combination of Ki67 and PSA did not give additional prognostic value. The results suggest immunohistochemical scoring of PSA to have potential to improve identification of patients responding well to ADT alone.PMID:37713321 | DOI:10.1080/0284186X.2023.2254480
Source: Acta Oncologica - September 15, 2023 Category: Cancer & Oncology Authors: Vasiliki Spyratou Eva Freyhult Anders Bergh Camilla Thellenberg-Karlsson Pernilla Wikstr öm Karin Wel én Andreas Josefsson Source Type: research
A systematic planning method to spare the rectal wall in radiotherapy of prostate cancer
Acta Oncol. 2023 Sep 15:1-4. doi: 10.1080/0284186X.2023.2252587. Online ahead of print.NO ABSTRACTPMID:37712583 | DOI:10.1080/0284186X.2023.2252587
Source: Acta Oncologica - September 15, 2023 Category: Cancer & Oncology Authors: Kirsten Jakobsen Laura Patricia Kaplan Romain Marsguerra Marko Bebek Kenneth Francis Hoffland Eva Samsoee Hinsby Source Type: research
Erratum: Metastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized Treatment
Am Soc Clin Oncol Educ Book. 2023 Jun;43:e390166CX1. doi: 10.1200/EDBK_390166CX1.NO ABSTRACTPMID:37713646 | DOI:10.1200/EDBK_390166CX1
Source: Clinical Prostate Cancer - September 15, 2023 Category: Cancer & Oncology Source Type: research
Prehabilitative versus rehabilitative exercise in prostate cancer patients undergoing prostatectomy
CONCLUSION: Pre-surgical exercise enhanced strength and function, protecting against post-surgery declines. Although exercise post-surgery is beneficial for recouping strength and function, where possible men undergoing prostatectomy are encouraged to exercise pre-surgery.TRIAL REGISTRATION: ACTRN12617001115325 registered 31 July 2017.PMID:37712960 | DOI:10.1007/s00432-023-05409-3
Source: Clinical Prostate Cancer - September 15, 2023 Category: Cancer & Oncology Authors: Favil Singh Robert U Newton Dennis R Taaffe Pedro Lopez Jeff Thavaseelan Matthew Brown Elayne Ooi Kazunori Nosaka Dickon Hayne Daniel A Galv ão Source Type: research
A Case of Metastatic Papillary Thyroid Carcinoma in Neck Lymph Nodes Without Primary Tumor in Thyroid Gland
We report the case of a 63-year-old male who had a left neck level II palpable mass. A left cervical mass had previously undergone 2 central needle biopsies, but only atypical cells had been identified. His prior medical history included surgical treatment for prostate cancer 11 years ago. There was no suspicious primary tumor in the endoscopic examination. After the excisional biopsy, the pathologic finding was metastatic papillary carcinoma from the thyroid, and there were no aberrant findings in the thyroid sonography. The patient underwent a complete thyroidectomy, bilateral central neck dissection (CND), and left leve...
Source: Ear, Nose and Throat Journal - September 15, 2023 Category: ENT & OMF Authors: Sung Ha Jung Joo Hyun Park Junyoung Kim Nayeon Choi Source Type: research
In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer"
Oncologist. 2023 Sep 14:oyad264. doi: 10.1093/oncolo/oyad264. Online ahead of print.NO ABSTRACTPMID:37706534 | DOI:10.1093/oncolo/oyad264
Source: The Oncologist - September 14, 2023 Category: Cancer & Oncology Authors: Luca F Valle Nicholas G Nickols Kosj Yamoah Isla P Garraway Kara N Maxwell Julie A Lynch Source Type: research
Pain-related stigma in patients with breast, colon, prostate or lung cancer : Results of a bicentric register-based cross-sectional study
CONCLUSIONS: Our findings support the assumption that the experience of pain can have an impact on the perceived stigmatization of cancer patients. Depression might influence the perceived stigmatization. Therefore, this group of patients should receive special attention and psycho-oncological care in clinical practice. Further research on the course and mechanisms of action of pain-related perceived stigmatization is also required.PMID:37710022 | DOI:10.1007/s00482-023-00752-3
Source: Schmerz - September 14, 2023 Category: Anesthesiology Authors: A Roicke P Esser B Hornemann J Ernst Source Type: research
In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer"
Oncologist. 2023 Sep 14:oyad264. doi: 10.1093/oncolo/oyad264. Online ahead of print.NO ABSTRACTPMID:37706534 | DOI:10.1093/oncolo/oyad264
Source: The Oncologist - September 14, 2023 Category: Cancer & Oncology Authors: Luca F Valle Nicholas G Nickols Kosj Yamoah Isla P Garraway Kara N Maxwell Julie A Lynch Source Type: research
